Article · 2013
Conference abstractPublished 11 Dec 2017
Guidelines for Beta Blocker utilization post MI / CABG
American University Hospital, Lebanon
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Beta Blockers have been utilized routinely in patients with ischemic heart disease for several decades. Multiple large randomized clinical trials have examined their efficacy in several patient populations: Stable angina, myocardial infarction, congestive heart failure, post PCI, and post CABG. Their efficacy has been shown to be modulated by several factors including reperfusion status post MI, extent of myocardial ischemia, and degree of left ventricular dysfunction. In this workshop we will examine the pivotal trials that examined the efficacy of beta blockers in the MI and CABG population of patients and we will review the current ACC/AHA and ESC guidelines for their utilization in these patient subgroups.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Short communication · 23 Aug 2021
Identification and Management of Post-Traumatic Paroxysmal Sympathetic Hyperactivity: Role of Beta-Blockers
Conference abstract · 11 Nov 2019
Perioperative use of β-blockers reduce the risk of developing postoperative AF in patients undergoing CABG
Conference abstract · 1 Mar 2020
Critical care 2019; Prospective study of preoperative patients for CABG: Was the P2Y12 inhibitor stopped according to the guidelines- Mohammad M R Mirah- NHS England
Conference abstract · 11 Nov 2019
Prospective study of preoperative patients for CABG: Was the P2Y12 inhibitor stopped according to the guidelines?
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- BylineArticles whose byline prints “Habib Dakik”
